Calcium Channel Blockers and the Risk of Exacerbation in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Study of 48,488 Outpatients

Calcium Channel Blockers and the Risk of Exacerbation in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Study of 48,488 Outpatients

Patients with chronic obstructive pulmonary disease (COPD) are prone to developing arterial hypertension, and many patients are treated with the calcium channel blocker amlodipine. However, it remains unclear whether using this drug potentially affects the risk of acute severe exacerbations (AECOPD)...

Full description

Bibliographic Details
Main Authors: Ema Rastoder, Pradeesh Sivapalan, Josefin Eklöf, Imane Achir Alispahic, Alexander Svorre Jordan, Christian B. Laursen, Jørgen Vestbo, Christine Jenkins, Rune Nielsen, Per Bakke, Gustavo Fernandez-Romero, Daniel Modin, Niklas Johansen, Filip Soeskov Davidovski, Tor Biering-Sørensen, Jørn Carlsen, Jens Ulrik Stæhr Jensen
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Biomedicines
Subjects:
COPD
calcium channel blockers
thiazide
exacerbations
amlodipine
bendroflumethiazide
Online Access:https://www.mdpi.com/2227-9059/11/7/1974

Internet

https://www.mdpi.com/2227-9059/11/7/1974

Similar Items